An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown ...

Pulmonary embolism accounts for 10–15% of all paediatric venous thromboembolism (VTE) events, with an annual incidence of 0·14–0·9 per 100 000 children.1,2 Although rare, pulmonary embolism is a ...

In this multicentre, prospective, observational, diagnostic accuracy study of children with suspected pulmonary embolism in ...

Patients experiencing life-threatening diabetic ketoacidosis (DKA) require quick action, diligent care and close monitoring ...

Cefazolin demonstrated equivalent survival rates and lower kidney injury risks compared to standard antistaphylococcal penicillins in a new trial.

Jessica Nave, MD, vice president for middle revenue cycle at Emory Healthcare and assistant professor of medicine in Emory’s division of hospital medicine, both in Atlanta, summarized the updated 2025 ...

Buy HRT online without the guesswork by reading our research-backed list of providers, which breaks down the process, prices, ...

Positive CHMP opinion is supported by data from the Phase 3 UP-AA clinical program in which upadacitinib achieved the primary endpoint of Severity of Alopecia Tool (SALT) score = 20 and key ...

If approved, upadacitinib is expected to be the first systemic medication for patients with non-segmental vitiligo, addressing important treatment needs ...

(Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has approved Trodelvy ® (sacituzumab govitecan-hziy), a first-in-class Trop-2-directed antibody-drug conjugate (ADC), ...

Pettit, MD, discussed the potential of using treatment earlier in polycythemia vera to alter the disease course. During a ...

The emergence of immunotherapy for esophageal cancer provided a glimmer of hope to patients and clinicians affected by the historically poor-prognosis disease. The glimmer has not only persisted but ...